FindTrial
Sign In

12-month DAPT

DRUG3 trials

Sponsors

Kyoto University, Graduate School of Medicine, Kindai University

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionCoronary Artery DiseasePercutaneous Coronary InterventionPlatelet Aggregation InhibitorsST-segment Elevation Myocardial Infarction (STEMI)

Phase 4

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
CompletedNCT02619760
Kyoto University, Graduate School of MedicineCoronary Artery Disease
Start: 2015-12-31End: 2023-12-31Updated: 2024-06-14
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
Active, not recruitingNCT03462498
Kyoto University, Graduate School of MedicineAcute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease +2
Start: 2018-04-02End: 2026-03-31Updated: 2024-06-14
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
RecruitingNCT05709626
Kindai UniversityST-segment Elevation Myocardial Infarction (STEMI)
Start: 2023-02-28End: 2028-01-04Target: 2258Updated: 2023-03-01

Related Papers

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.
2026-03-18
Prasugrel monotherapy versus 12-month dual antiplatelet therapy in STEMI patients undergoing intravascular imaging-guided PCI: Study design and rationale of the randomized PREMIUM trial.
2025-12-11
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
JACC Asia2023-01-1015 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
2022-12-1411 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
Circulation Cardiovascular Interventions2022-08-0128 citations
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
JAMA Cardiology2022-03-02274 citations
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial
Circulation Cardiovascular Interventions2021-05-0130 citations
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2.
2020-11-128 citations
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
2020-02-2141 citations
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
JAMA2019-06-25800 citations